Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients.
about
Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerationsClinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosisOverview and safety of fingolimod hydrochloride use in patients with multiple sclerosis.Multiple sclerosis reactivation postfingolimod cessation: is it IRIS?Patient experience and practice trends in multiple sclerosis - clinical utility of fingolimod.Treatment options for patients with multiple sclerosis who have a suboptimal response to interferon-β therapy.Impact of Cost-Sharing Increases on Continuity of Specialty Drug Use: A Quasi-Experimental Study.Neurological safety of fingolimod: An updated review
P2860
Q26765300-ECED78C7-10A7-463C-AC39-69DACB00E21AQ26771635-4F6E3477-0145-42AA-B538-F61278E823E4Q30458371-641E28E7-28EC-4AE3-ACEA-97FF1D840679Q34365360-C9B541EF-1E88-473F-ABA4-3B5A49B34FD7Q35659134-3130B33D-B400-4BB5-9598-5F6F125B379FQ38163046-ADAC139C-F254-4289-B67A-143535166C7CQ38665413-54ACE7D6-7D0B-4AB1-B975-438DCCDF19DFQ41553443-6DF312C8-684D-4393-A9FE-5DB5B48DCED4
P2860
Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients.
@en
Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients.
@nl
type
label
Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients.
@en
Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients.
@nl
prefLabel
Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients.
@en
Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients.
@nl
P2093
P2860
P50
P1433
P1476
Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients
@en
P2093
P2860
P2888
P304
P356
10.1007/S00415-012-6744-7
P577
2012-11-16T00:00:00Z